Thomas Högberg
Corporate Officer/Principal at Royal Institute of Technology
Profile
Thomas Högberg is Vice President of Chemistry and ADME for 7TM Pharma A/S.
He is an Associate Professor of the Royal Institute of Technology.
Dr. Högberg is a Director of Medicinal Chemistry in the Swedish Academy of Pharmaceutical Sciences and a Member of the Editorial Advisory Board of "Current Medicinal Chemistry" and "Medicinal Chemistry".
Most recently, he worked at Astra USA, Inc. from 1971 to 2000.
He was Director of Medicinal Chemistry for Astra Research Centre.
Previously, he worked at Astra Draco AB and ALK-Abéllo AS.
Dr. Högberg received an MSc degree in Chemistry from the Lund Institute of Technology and a PhD in Organic Chemistry from the University of Uppsala.
Thomas Högberg active positions
Companies | Position | Start |
---|---|---|
Royal Institute of Technology | Corporate Officer/Principal | - |
Former positions of Thomas Högberg
Companies | Position | End |
---|---|---|
Astra USA, Inc. | Corporate Officer/Principal | 1999-12-31 |
ALK-ABELLÓ A/S | Corporate Officer/Principal | - |
Astra Draco AB | Corporate Officer/Principal | - |
7TM A/S
7TM A/S Pharmaceuticals: MajorHealth Technology 7TM A/S performs research and development within biotechnology. It engages in clinical development of drugs focusing on obesity and gastrointestinal diseases. The company was founded by Thue Walter Schwartz, Anders Fink Vadsholt, Mette Kirstine Agger, Christian Ellebæk Elling, and Peter Moldt on January 1, 2000 and is headquartered in Hørsholm, Denmark. | Corporate Officer/Principal | - |
Training of Thomas Högberg
Faculty of Engineering, Lund University | Graduate Degree |
University of Uppsala | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ALK-ABELLÓ A/S | Health Technology |
Private companies | 3 |
---|---|
7TM A/S
7TM A/S Pharmaceuticals: MajorHealth Technology 7TM A/S performs research and development within biotechnology. It engages in clinical development of drugs focusing on obesity and gastrointestinal diseases. The company was founded by Thue Walter Schwartz, Anders Fink Vadsholt, Mette Kirstine Agger, Christian Ellebæk Elling, and Peter Moldt on January 1, 2000 and is headquartered in Hørsholm, Denmark. | Health Technology |
Astra USA, Inc. | |
Astra Draco AB |
- Stock Market
- Insiders
- Thomas Högberg